Jazirehi, A. R.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities

Cal, C., Garban, H., Jazirehi, A., Yeh, C., Mizutani, Y., Bonavida, B.

Journal:

Current Medicinal Chemistry - Anti-Cancer Agents

Year:

2003

Language:

english

File:

PDF, 253 KB

english, 2003

2

Quantitative structure–Activity relationships of phenolic compounds causing apoptosis

Corwin Hansch, Benjamin Bonavida, Ali R. Jazirehi, J.John Cohen, Cheri Milliron, Alka Kurup

Journal:

Bioorganic & Medicinal Chemistry

Year:

2003

Language:

english

File:

PDF, 142 KB

english, 2003

3

QSAR of apoptosis induction in various cancer cells

Corwin Hansch, Ali Jazirehi, Suresh Babu Mekapati, Rajni Garg, Benjamin Bonavida

Journal:

Bioorganic & Medicinal Chemistry

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

4

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance

Vega, Mario I, Huerta-Yepaz, Sara, Garban, Hermes, Jazirehi, Ali, Emmanouilides, Christos, Bonavida, Benjamin

Journal:

Year:

2004

Language:

english

File:

PDF, 374 KB

english, 2004

5

Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression

Huerta-Yepez, Sara, Vega, Mario, Jazirehi, Ali, Garban, Hermes, Hongo, Fumiya, Cheng, Genhong, Bonavida, Benjamin

Journal:

Year:

2004

Language:

english

File:

PDF, 417 KB

english, 2004

6

Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention

Jazirehi, Ali R, Bonavida, Benjamin

Journal:

Year:

2005

Language:

english

File:

PDF, 329 KB

english, 2005

7

Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis

Vega, Mario I, Huerta-Yepez, Sara, Jazirehi, Ali R, Garban, Hermes, Bonavida, Benjamin

Journal:

Year:

2005

Language:

english

File:

PDF, 357 KB

english, 2005

8

Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation

Fumiya Hongo, Hermes Garban, Sara Huerta-Yepez, Mario Vega, Ali R. Jazirehi, Yoichi Mizutani, Tsuneharu Miki, Benjamin Bonavida

Journal:

Biochemical and Biophysical Research Communications

Year:

2005

Language:

english

File:

PDF, 460 KB

english, 2005

9

Proteasome Inhibition Blocks NF- B and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs

Jazirehi, A. R., Economou, J. S.

Journal:

Molecular Cancer Therapeutics

Year:

2012

Language:

english

File:

PDF, 849 KB

english, 2012

10

T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy

Jon G Quatromoni, Yue Wang, Dan D Vo, Lilah F Morris, Ali R Jazirehi, William McBride, Talal Chatila, Richard C Koya, James S Economou

Journal:

Journal of Translational Medicine

Year:

2012

Language:

english

File:

PDF, 584 KB

english, 2012

11

The NF-κB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs

Vega, Mario I., Martinez-Paniagua, Melissa, Jazirehi, Ali R., Huerta-Yepez, Sara, Umezawa, Kazuo, Martinez-Maza, Otoniel, Bonavida, Benjamin

Journal:

Leukemia and Lymphoma

Year:

2008

Language:

english

File:

PDF, 1.11 MB

english, 2008

12

Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway

Jazirehi, A. R., Kurdistani, S. K., Economou, J. S.

Journal:

The Journal of Immunology

Year:

2014

Language:

english

File:

PDF, 1.74 MB

english, 2014

13

Inhibition of Yin Yang 1-Dependent Repressor Activity of DR5 Transcription and Expression by the Novel Proteasome Inhibitor NPI-0052 Contributes to its TRAIL-Enhanced Apoptosis in Cancer Cells

Baritaki, S., Suzuki, E., Umezawa, K., Spandidos, D. A., Berenson, J., Daniels, T. R., Penichet, M. L., Jazirehi, A. R., Palladino, M., Bonavida, B.

Journal:

The Journal of Immunology

Year:

2008

Language:

english

File:

PDF, 946 KB

english, 2008

14

Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells

Xu, J., Pope, S. D., Jazirehi, A. R., Attema, J. L., Papathanasiou, P., Watts, J. A., Zaret, K. S., Weissman, I. L., Smale, S. T.

Journal:

Proceedings of the National Academy of Sciences

Year:

2007

Language:

english

File:

PDF, 2.86 MB

english, 2007

15

Rituximab-Mediated Sensitization of B-Non-Hodgkin's Lymphoma (NHL) to Cytotoxicity Induced by Paclitaxel, Gemcitabine, and Vinorelbine

Emmanouilides, Christos, Jazirehi, Ali R., Bonavida, Benjamin

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

2002

Language:

english

File:

PDF, 179 KB

english, 2002

16

Inhibition of the Raf-MEK1/2-ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin's Lymphoma B Cells by Rituximab

Jazirehi, A. R.

Journal:

Cancer Research

Year:

2004

Language:

english

File:

PDF, 613 KB

english, 2004

17

Epigenomics and targeted therapy in cancer

Nazarian, Ramin, Jazirehi, Ali R

Journal:

Year:

2014

Language:

english

File:

PDF, 787 KB

english, 2014

18

Rituximab-Induced Inhibition of YY1 and Bcl-xL Expression in Ramos Non-Hodgkin's Lymphoma Cell Line via Inhibition of NF- B Activity: Role of YY1 and Bcl-xL in Fas Resistance and Chemoresistance, Respectively

Vega, M. I., Jazirehi, A. R., Huerta-Yepez, S., Bonavida, B.

Journal:

The Journal of Immunology

Year:

2005

Language:

english

File:

PDF, 522 KB

english, 2005

19

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

Vega, M. I., Huerta-Yepez, S., Martinez-Paniagua, M., Martinez-Miguel, B., Hernandez-Pando, R., Gonzalez-Bonilla, C. R., Chinn, P., Hanna, N., Hariharan, K., Jazirehi, A. R., Bonavida, B.

Journal:

Clinical Cancer Research

Year:

2009

Language:

english

File:

PDF, 845 KB

english, 2009

20

Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy

Jazirehi, A. R., Vega, M. I., Bonavida, B.

Journal:

Cancer Research

Year:

2007

Language:

english

File:

PDF, 991 KB

english, 2007

21

Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor-CTL Interaction

Jazirehi, A. R., Baritaki, S., Koya, R. C., Bonavida, B., Economou, J. S.

Journal:

Cancer Research

Year:

2011

Language:

english

File:

PDF, 708 KB

english, 2011

22

Research Highlights: Significance of epigenetic modifiers in cancer progression: potential for therapy

Jazirehi, Ali R, Arle, Dylan, Wenn, Peter B

Journal:

Year:

2012

Language:

english

File:

PDF, 501 KB

english, 2012

23

Mechanisms of nitric oxide-mediated inhibition of EMT in cancer

Baritaki, Stavroula, Huerta-Yepez, Sara, Sahakyan, Anna, Karagiannides, Iordanis, Bakirtzi, Kyriaki, Jazirehi, Ali, Bonavida, Benjamin

Journal:

Year:

2010

Language:

english

File:

PDF, 2.63 MB

english, 2010

24

Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review).

Bonavida, B, Ng, C P, Jazirehi, A, Schiller, G, Mizutani, Y

Journal:

International Journal of Oncology

Year:

1999

Language:

english

File:

PDF, 2.83 MB

english, 1999

25

Editorial [Hot Topic: Functional Complementation, Molecular Targeted Strategies, and Chemo/Immuno-Sensitization in Cancer Treatment: Hurdles and Solutions (Guest Editor: A.R. Jazirehi)]

R. Jazirehi, Ali

Journal:

Current Drug Delivery

Year:

2012

Language:

english

File:

PDF, 108 KB

english, 2012

26

Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy

Jazirehi, Ali R.

Journal:

Anti-Cancer Drugs

Year:

2010

Language:

english

File:

PDF, 173 KB

english, 2010

27

Research Highlights

Jazirehi, Ali R, Torres-Collado, Antoni X

Journal:

Year:

2013

Language:

english

File:

PDF, 573 KB

english, 2013

28

Research Highlights: Highlights from the latest articles in epigenomics

Jazirehi, Ali R, Torres-Collado, Antoni X, Nazarian, Ramin

Journal:

Year:

2013

Language:

english

File:

PDF, 540 KB

english, 2013

29

Overcoming Resistance of Human Non-Hodgkin’s Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors

Torres-Collado, Antoni, Jazirehi, Ali

Journal:

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

30

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor)

Torres-Collado, Antoni, Knott, Jeffrey, Jazirehi, Ali

Journal:

Year:

2018

Language:

english

File:

PDF, 305 KB

english, 2018

31

Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Masood, Aisha, A. Shahshahan, Mohammad, R. Jazirehi, Ali

Journal:

Current Drug Delivery

Year:

2012

Language:

english

File:

PDF, 155 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски